Table 4.
Differences in Methadone Dose and QTc Interval at Two Weeks between Patients with and without Baseline QT Prolongation
No baseline QTc prolongation (n = 47) | Baseline QTc prolongation (n = 17) | p value | |
---|---|---|---|
Median methadone dose in mg (Q1–Q3) | 21 (10–30) | 20 (10–34) | 0.56 |
Mean QTc in ms (SD) | 426 (18) | 440 (28) | 0.063 |
Median QTc in ms (Q1–Q3) | 429 (420–435) | 435 (425–451) | 0.042 |
QTc > ULN | 8 (17%) | 12 (71%) | <0.001 |
QTc > 500 | 0 (0%) | 1 (6%) | 0.094 |
QTc > 10% above baseline | 4 (9%) | 1 (6%) | 0.73 |
QTc > 25% above baseline | 0 (0%) | 0 (0%) | — |